KS
Kamal S. Saini
Also known as: Kamal Veer Singh Saini
Fortrea Inc., Cambridge University Hospitals NHS Foundation Trust, Rajiv Gandhi University of Health Sciences, Lalit Narayan Mithila University, Mahatma Gandhi Mission Medical College
Employment
-
Fortrea Inc. Vice President, Global Therapeutic Area Leader, Oncology
-
Cambridge University Hospitals NHS Foundation Trust Honorary Clinical Fellow
-
Mahatma Gandhi Mission Medical College Assistant Professor
-
HCG Bangalore Institute of Oncology Consultant Medical Oncologist
-
Labcorp Drug Development Inc Executive Medical Director
-
East Suffolk and North Essex NHS Foundation Trust Locum Consultant Medical Oncologist
-
Breast International Group Associate Scientific Director
-
Institut Jules Bordet Medical Advisor, BrEAST Data Centre
Education
-
Rajiv Gandhi University of Health Sciences DM (Medical Oncology)
-
Lalit Narayan Mithila University MBBS
-
University of Mumbai MD (General Medicine)
Projects & Funding
Projects & funding information is unavailable.
Publications (139)
- Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework Save
- Gene–environment interactions: The exposome and cancer susceptibility Save
- Socioeconomic inequities and the exposome: A double burden in low- and middle-income countries Save
- The future of exposomics: Pathways to address cancer disparities in low- and middle-income countries Save
- Real-world effectiveness of MET inhibitors versus immunotherapy ± chemotherapy in 1L for patients with MET exon 14 skipping mutations in non-small cell lung cancer. Save
- Treatment strategies in metastatic NSCLC after progression to immuno-chemotherapy: A random-effects network meta-analysis of phase III trials. Save
- Human Absorption, Metabolism, and Excretion (hAME) Mass Balance Studies in Patients With Cancer Save
- Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis Save
- Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers Save
- Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumors Save